Ganciclovir Completed Phase 2 Trials for Cytomegalovirus Retinitis / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00000766CMV Retinitis Retreatment Trial
NCT00002156A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
NCT00001061Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS